Agency Information Collection Activities: Proposed Collection; Comment Request, 30123-30125 [2019-13608]
Download as PDF
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 123 / Wednesday, June 26, 2019 / Notices
Exchanges. Section 1311(c)(3) of the
Patient Protection and Affordable Care
Act directs the Secretary to develop a
system to rate QHPs on the basis of
quality and price and requires
Exchanges to display this quality rating
information on their respective
websites. Section 1311(c)(4) of the
Patient Protection and Affordable Care
Act requires the Secretary to develop an
enrollee satisfaction survey system to
assess enrollee experience with each
QHP (with more than 500 enrollees in
the previous year) offered through an
Exchange. Section 1311(h) requires
QHPs to contract with certain hospitals
that meet specific patient safety and
health care quality standards.
This collection of information is
necessary to provide adequate and
timely health care quality information
for consumers, regulators, and
Exchanges as well as to collect
information to appropriately monitor
and provide a process for a survey
vendor to appeal HHS’ decision to not
approve a QHP Enrollee Survey vendor
application. Form Number: CMS–10520
(OMB control number: 0938–1249);
Frequency: Annually; Affected Public:
Public sector (Individuals and
Households), Private sector (Business or
other for-profits and Not-for-profit
institutions); Number of Respondents:
264. Total Annual Responses: 264; Total
Annual Hours: 348,764. For policy
questions regarding this collection
contact Nidhi Singh Shah at 301–492–
5110. Type of Information Collection
Request: Revision of a currently
approved collection.
2. Title of Information Collection:
State Agency Sheets for Verifying
Exclusions from the Inpatient
Prospective Payment System and
Supporting Regulations—Rehabilitation
Unit/Rehabilitation Hospital Criteria
Worksheets; Use: The purpose of this
information collection is to renew forms
CMS–437A and 437B. Inpatient
Rehabilitation Facility (IRF) hospitals
and units must initially attest that they
meet the Inpatient Prospective Payment
System (IPPS) exclusion criteria set
forth at 42 CFR 412.20 to 412.29 prior
to being placed into IPPS exempt status.
Form CMS–437A must be completed by
IRF units and form CMS–437B must be
completed by IRF hospitals.
For first time verification requests for
exclusion from the IPPS, an IRF unit or
hospital must notify the Regional Office
(RO) servicing the State in which it is
located that it believes it meets the
criteria for exclusion from the IPPS.
Currently, all new IRF units or hospitals
must provide written certification that
the inpatient population it intends to
serve will meet the requirements of the
VerDate Sep<11>2014
18:47 Jun 25, 2019
Jkt 247001
IPPS exclusion criteria for IRFs. The
completed CMS–437A and 437B forms
are submitted to the State Agency (SA)
no later than 5 months before the date
the IRF unit or hospital would become
subject to Inpatient Rehabilitation
Facility Prospective Payment System
(IRF–PPS). For IRF units and hospitals
already excluded from the IPPS, annual
onsite re-verification surveys by the SA
are no longer required. IRF units and
hospitals must now re-attest to meeting
the exclusion criteria every 3 years
thereafter.
IRF units and hospitals that have
already been excluded need not reapply
for exclusion. These facilities will
automatically be reevaluated yearly to
determine whether they continue to
meet the exclusion criteria. For the triannual re-verification, IRF units and
hospitals will be provided with a copy
of the appropriate CMS–437 worksheet
at least 5-months prior to the beginning
of its cost reporting period, so that the
IRF unit or hospital official may
complete and sign an attestation
statement and complete and return the
appropriate form CMS–437A or CMS–
437B at least 5-months prior to the
beginning of the cost reporting period.
However, Fiscal Intermediaries (FIs)
will continue to verify, on an annual
basis, compliance with the 60 percent
rule (42 CFR 412.29(b)(2)) for IRF units
and hospitals through a sample of
medical records and the SA will verify
the medical director requirement.
The SA will notify the RO at least 60
days prior to the end of the IRF unit’s
or hospital’s cost reporting period of the
status of compliance or non-compliance
with the payment requirements. The
information collected on the 437A and
437B forms, along with other
information submitted by the IRF is
necessary for determining the IRF’s IPPS
exclusion status. Form Number: CMS–
437A and CMS–437B (OMB control
number: 0938–0986); Frequency: triannually; Affected Public: Private sector
(Business or other for-profits); Number
of Respondents: 1,126; Total Annual
Responses: 1,126; Total Annual Hours:
1,126. (For policy questions regarding
this collection contact Caroline Gallaher
at 410–786–8705.)
Dated: June 21, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–13607 Filed 6–25–19; 8:45 am]
BILLING CODE 4120–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
30123
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–153, CMS–R–
235, CMS–10439, CMS–10594, CMS–10328
and CMS–460]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
August 26, 2019.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number _________, Room C4–
26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
SUMMARY:
E:\FR\FM\26JNN1.SGM
26JNN1
30124
Federal Register / Vol. 84, No. 123 / Wednesday, June 26, 2019 / Notices
jbell on DSK3GLQ082PROD with NOTICES
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–R–153 Medicaid Drug Use
Review (DUR) Program
CMS–R–235 Data Use Agreement
(DUA) Form
CMS–10439 Data Collection to
Support Eligibility Determinations
and Enrollment for Employers in
the Small Business Health Options
Program
CMS–10594 Provider Network
Coverage Data Collection
CMS–10328 Medicare Self-Referral
Disclosure Protocol
CMS–460 Medicare Participation
Agreement for Physicians and
Suppliers
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
VerDate Sep<11>2014
18:47 Jun 25, 2019
Jkt 247001
approved collection; Title of
Information Collection: Medicaid Drug
Use Review (DUR) Program; Use: States
must provide for a review of drug
therapy before each prescription is filled
or delivered to a Medicaid patient. This
review includes screening for potential
drug therapy problems due to
therapeutic duplication, drug-disease
contraindications, drug-drug
interactions, incorrect drug dosage or
duration of drug treatment, drug-allergy
interactions, and clinical abuse/misuse.
Pharmacists must make a reasonable
effort to obtain, record, and maintain
Medicaid patient profiles. These profiles
must reflect at least the patient’s name,
address, telephone number, date of
birth/age, gender, history, e.g., allergies,
drug reactions, list of medications, and
pharmacist’s comments relevant to the
individual’s drug therapy.
The States must conduct RetroDUR
which provides for the ongoing periodic
examination of claims data and other
records in order to identify patterns of
fraud, abuse, inappropriate or medically
unnecessary care. Patterns or trends of
drug therapy problems are identified
and reviewed to determine the need for
intervention activity with pharmacists
and/or physicians. States may conduct
interventions via telephone,
correspondence, or face-to-face contact.
Annual reports are submitted to CMS
for the purposes of monitoring
compliance and evaluating the progress
of States’ DUR programs. The
information submitted by States is
reviewed and results are compiled by
CMS in a format intended to provide
information, comparisons, and trends
related to States’ experiences with DUR.
States benefit from the information and
may enhance their programs each year
based on State reported innovative
practices that are compiled by CMS
from the DUR annual reports. Form
Number: CMS–R–153 (OMB control
number: 0938–0659); Frequency: Yearly,
quarterly, and occasionally; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
51; Total Annual Responses: 663; Total
Annual Hours: 41,004. (For policy
questions regarding this collection
contact Mike Forman at 410–786–2666.)
2. Type of Information Collection
Request: Reinstatement with change of a
currently approved collection; Title of
Information Collection: Data Use
Agreement (DUA) Form; Use: The
Privacy Act of 1974 allows for
discretionary releases of data
maintained in Privacy Act protected
systems of records under § 552a(b)
(Conditions of Disclosure). The mandate
to account for disclosures of data under
the Privacy Act is found at § 552a(c)
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
(Accounting of Certain Disclosures).
This section states that certain
information must be maintained
regarding disclosures made by each
agency. This information is: Date,
Nature, Purpose, and Name/Address of
Recipient. Section 552a(e) sets the
overall Agency Requirements that each
agency must meet in order to maintain
records under the Privacy Act.
The Data Use Agreement (DUA) form
is needed as part of the review of each
CMS data request to ensure compliance
with the requirements of the Privacy Act
for disclosures that contain PII. The
DUA form also provides data requestors
and custodians with a formal means to
agree to the data protection and
destruction statutory and regulatory
requirements of CMS’ PII data.
When entities, such as academic,
federal or state agency researchers or
CMS contractors request CMS PII/PHI
data, they enter into a Data Use
Agreement (DUA) with CMS. The DUA
stipulates that the recipient of CMS data
must properly protect the data
according to all applicable data security
standards and also provide for its
appropriate destruction at the
completion of the project/study or the
expiration date of the DUA. The DUA
form enables the data recipient and
CMS to document the request and
approval for release of CMS data. Form
Number: CMS–R–235 (OMB control
number: 0938–0734); Frequency: Yearly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
9,200; Total Annual Responses: 9,200;
Total Annual Hours: 2,900. (For policy
questions regarding this collection
contact Kari A. Gaare at 410–786–8612.)
3. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Data Collection
to Support Eligibility Determinations
and Enrollment for Employers in the
Small Business Health Options Program;
Use: Section 1311(b)(1)(B) of the
Affordable Care Act directs that the
SHOP assist qualified small employers
in facilitating the enrollment of their
employees in QHPs offered in the small
group market. Section 1311(c)(1)(F) of
the Affordable Care Act directs HHS to
establish criteria for certification of
health plans as QHPs and plans to
utilize a uniform enrollment form for
qualified employers. Further, section
1311(c)(5)(B) directs HHS to develop a
website that assists employers in
determining if they are eligible to
participate in SHOP. Form Number:
CMS–10439 (OMB control number:
0938–1193); Frequency: Annually;
Affected Public: Private Sector, Business
or other for-profits, Not-for-profits
E:\FR\FM\26JNN1.SGM
26JNN1
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 123 / Wednesday, June 26, 2019 / Notices
institutions; Number of Respondents:
6,000; Total Annual Responses: 6,000;
Total Annual Hours: 960. (For policy
questions regarding this collection
contact Michele Oshman at 410–786–
4396.)
4. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Provider
Network Coverage Data Collection; Use:
The Affordable Care Act (ACA)
established competitive private health
insurance markets called Marketplaces,
or Exchanges, which gave millions of
Americans and small businesses access
to affordable, quality insurance options
that meet certain requirements. These
requirements include ensuring
sufficient choice of providers and
providing information to enrollees and
prospective enrollees on the availability
of in-network and out-of-network
providers. This information collection
notice is for two of the standards from
the HHS Notice of Benefit and Payment
Parameters for 2017 (CMS–9937–F) final
rule: One applying in the FFE and one
applying to all QHPs. Specifically,
under 45 CFR 156.230(d) and
156.230(e), we require notification
requirements for enrollees in cases
where a provider leaves the network
and for cases where an enrollee might
be seen by an out of network ancillary
provider in in-network setting. These
standards will help inform consumers
about his or her health plan coverage to
better make cost effective choices. The
Centers for Medicare and Medicaid
Services (CMS) is updating an
information collection request (ICR) in
connection with these standards. The
burden estimates for this ICR included
in this package reflects the additional
time and effort for QHP issuers to
provide these notifications to enrollees.
Form Number: CMS–10594 (OMB
control number: 0938–1302); Frequency:
Yearly; Affected Public: Private Sector
(business or other for-profits, not-forprofit institutions); Number of
Respondents: 470; Total Annual
Responses: 356,260; Total Annual
Hours: 194,250. (For policy questions
regarding this collection contact
Arunima Shukla at 410–786–5017.)\
5. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Medicare SelfReferral Disclosure Protocol; Use:
Section 6409 of the ACA requires the
Secretary to establish a voluntary selfdisclosure process that allows providers
of services and suppliers to self-disclose
actual or potential violations of section
1877 of the Act. In addition, section
6409(b) of the ACA gives the Secretary
VerDate Sep<11>2014
18:47 Jun 25, 2019
Jkt 247001
authority to reduce the amounts due
and owing for the violations. To
determine the nature and extent of the
noncompliance and the appropriate
amount by which an overpayment may
be reduced, the Secretary must collect
relevant information regarding the
arrangements and financial
relationships at issue from disclosing
parties. The Secretary may also collect
supporting documentation, such as
contracts, leases, communications,
invoices, or other documents bearing on
the actual or potential violation(s). Most
of the information and documentation
required for submission to CMS in
accordance with the SRDP is
information that health care providers of
services and suppliers keep as part of
customary and usual business practices.
Form Number: CMS–10328 (OMB
control number: 0938–1106); Frequency:
Yearly; Affected Public: Private Sector
(business or other for-profits, not-forprofit institutions); Number of
Respondents: 470; Total Annual
Responses: 356,260; Total Annual
Hours: 194,250. (For policy questions
regarding this collection contact
Matthew Edgar at 410–786–0698.)
6. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Medicare
Participation Agreement for Physicians
and Suppliers; Use: Section 1842(h) of
the Social Security Act permits
physicians and suppliers to voluntarily
participate in Medicare Part B by
agreeing to take assignment on all
claims for services to Medicare
beneficiaries. The law also requires that
the Secretary provide specific benefits
to the physicians, suppliers and other
persons who choose to participate. The
CMS–460 is the agreement by which the
physician or supplier elects to
participate in Medicare. By signing the
agreement to participate in Medicare,
the physician, supplier, or their
authorized official agrees to accept the
Medicare-determined payment for
Medicare covered services as payment
in full and to charge the Medicare Part
B beneficiary no more than the
applicable deductible or coinsurance for
the covered services. For purposes of
this explanation, the term ‘‘supplier’’
means certain other persons or entities,
other than physicians, that may bill
Medicare for Part B services (e.g.,
suppliers of diagnostic tests, suppliers
of radiology services, durable medical
suppliers (DME) suppliers, nurse
practitioners, clinical social workers,
physician assistants). Institutions that
render Part B services in their outpatient
department are not considered
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
30125
‘‘suppliers’’ for purposes of this
agreement. Form Number: CMS–
460(OMB control number: 0938–0373);
Frequency: Yearly; Affected Public:
Private Sector (business or other forprofits); Number of Respondents:
29,000; Total Annual Responses:
29,000; Total Annual Hours: 7,250. (For
policy questions regarding this
collection contact Mark Baldwin at 410–
786–8139.)
Dated: June 21, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–13608 Filed 6–25–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–D–2223]
Clinical Investigations for Prostate
Tissue Ablation Devices; Draft
Guidance for Industry and Food and
Drug Administration Staff; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of the draft
guidance entitled ‘‘Clinical
Investigations for Prostate Tissue
Ablation Devices.’’ This draft guidance
provides recommendations for clinical
investigations for high intensity
ultrasound systems for prostate tissue
ablation and new types of prostatic
tissue ablation devices. This draft
guidance is not final nor is it in effect
at this time.
DATES: Submit either electronic or
written comments on the draft guidance
by August 26, 2019 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
E:\FR\FM\26JNN1.SGM
26JNN1
Agencies
[Federal Register Volume 84, Number 123 (Wednesday, June 26, 2019)]
[Notices]
[Pages 30123-30125]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13608]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-R-153, CMS-R-235, CMS-10439, CMS-10594, CMS-
10328 and CMS-460]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by August 26, 2019.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number _________, Room C4-26-05, 7500 Security Boulevard,
Baltimore, Maryland 21244-1850.
[[Page 30124]]
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-R-153 Medicaid Drug Use Review (DUR) Program
CMS-R-235 Data Use Agreement (DUA) Form
CMS-10439 Data Collection to Support Eligibility Determinations and
Enrollment for Employers in the Small Business Health Options Program
CMS-10594 Provider Network Coverage Data Collection
CMS-10328 Medicare Self-Referral Disclosure Protocol
CMS-460 Medicare Participation Agreement for Physicians and Suppliers
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicaid Drug Use
Review (DUR) Program; Use: States must provide for a review of drug
therapy before each prescription is filled or delivered to a Medicaid
patient. This review includes screening for potential drug therapy
problems due to therapeutic duplication, drug-disease
contraindications, drug-drug interactions, incorrect drug dosage or
duration of drug treatment, drug-allergy interactions, and clinical
abuse/misuse. Pharmacists must make a reasonable effort to obtain,
record, and maintain Medicaid patient profiles. These profiles must
reflect at least the patient's name, address, telephone number, date of
birth/age, gender, history, e.g., allergies, drug reactions, list of
medications, and pharmacist's comments relevant to the individual's
drug therapy.
The States must conduct RetroDUR which provides for the ongoing
periodic examination of claims data and other records in order to
identify patterns of fraud, abuse, inappropriate or medically
unnecessary care. Patterns or trends of drug therapy problems are
identified and reviewed to determine the need for intervention activity
with pharmacists and/or physicians. States may conduct interventions
via telephone, correspondence, or face-to-face contact.
Annual reports are submitted to CMS for the purposes of monitoring
compliance and evaluating the progress of States' DUR programs. The
information submitted by States is reviewed and results are compiled by
CMS in a format intended to provide information, comparisons, and
trends related to States' experiences with DUR. States benefit from the
information and may enhance their programs each year based on State
reported innovative practices that are compiled by CMS from the DUR
annual reports. Form Number: CMS-R-153 (OMB control number: 0938-0659);
Frequency: Yearly, quarterly, and occasionally; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 51; Total Annual
Responses: 663; Total Annual Hours: 41,004. (For policy questions
regarding this collection contact Mike Forman at 410-786-2666.)
2. Type of Information Collection Request: Reinstatement with
change of a currently approved collection; Title of Information
Collection: Data Use Agreement (DUA) Form; Use: The Privacy Act of 1974
allows for discretionary releases of data maintained in Privacy Act
protected systems of records under Sec. 552a(b) (Conditions of
Disclosure). The mandate to account for disclosures of data under the
Privacy Act is found at Sec. 552a(c) (Accounting of Certain
Disclosures). This section states that certain information must be
maintained regarding disclosures made by each agency. This information
is: Date, Nature, Purpose, and Name/Address of Recipient. Section
552a(e) sets the overall Agency Requirements that each agency must meet
in order to maintain records under the Privacy Act.
The Data Use Agreement (DUA) form is needed as part of the review
of each CMS data request to ensure compliance with the requirements of
the Privacy Act for disclosures that contain PII. The DUA form also
provides data requestors and custodians with a formal means to agree to
the data protection and destruction statutory and regulatory
requirements of CMS' PII data.
When entities, such as academic, federal or state agency
researchers or CMS contractors request CMS PII/PHI data, they enter
into a Data Use Agreement (DUA) with CMS. The DUA stipulates that the
recipient of CMS data must properly protect the data according to all
applicable data security standards and also provide for its appropriate
destruction at the completion of the project/study or the expiration
date of the DUA. The DUA form enables the data recipient and CMS to
document the request and approval for release of CMS data. Form Number:
CMS-R-235 (OMB control number: 0938-0734); Frequency: Yearly; Affected
Public: State, Local, or Tribal Governments; Number of Respondents:
9,200; Total Annual Responses: 9,200; Total Annual Hours: 2,900. (For
policy questions regarding this collection contact Kari A. Gaare at
410-786-8612.)
3. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Data Collection
to Support Eligibility Determinations and Enrollment for Employers in
the Small Business Health Options Program; Use: Section 1311(b)(1)(B)
of the Affordable Care Act directs that the SHOP assist qualified small
employers in facilitating the enrollment of their employees in QHPs
offered in the small group market. Section 1311(c)(1)(F) of the
Affordable Care Act directs HHS to establish criteria for certification
of health plans as QHPs and plans to utilize a uniform enrollment form
for qualified employers. Further, section 1311(c)(5)(B) directs HHS to
develop a website that assists employers in determining if they are
eligible to participate in SHOP. Form Number: CMS-10439 (OMB control
number: 0938-1193); Frequency: Annually; Affected Public: Private
Sector, Business or other for-profits, Not-for-profits
[[Page 30125]]
institutions; Number of Respondents: 6,000; Total Annual Responses:
6,000; Total Annual Hours: 960. (For policy questions regarding this
collection contact Michele Oshman at 410-786-4396.)
4. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Provider Network Coverage Data Collection; Use: The Affordable Care Act
(ACA) established competitive private health insurance markets called
Marketplaces, or Exchanges, which gave millions of Americans and small
businesses access to affordable, quality insurance options that meet
certain requirements. These requirements include ensuring sufficient
choice of providers and providing information to enrollees and
prospective enrollees on the availability of in-network and out-of-
network providers. This information collection notice is for two of the
standards from the HHS Notice of Benefit and Payment Parameters for
2017 (CMS-9937-F) final rule: One applying in the FFE and one applying
to all QHPs. Specifically, under 45 CFR 156.230(d) and 156.230(e), we
require notification requirements for enrollees in cases where a
provider leaves the network and for cases where an enrollee might be
seen by an out of network ancillary provider in in-network setting.
These standards will help inform consumers about his or her health plan
coverage to better make cost effective choices. The Centers for
Medicare and Medicaid Services (CMS) is updating an information
collection request (ICR) in connection with these standards. The burden
estimates for this ICR included in this package reflects the additional
time and effort for QHP issuers to provide these notifications to
enrollees. Form Number: CMS-10594 (OMB control number: 0938-1302);
Frequency: Yearly; Affected Public: Private Sector (business or other
for-profits, not-for-profit institutions); Number of Respondents: 470;
Total Annual Responses: 356,260; Total Annual Hours: 194,250. (For
policy questions regarding this collection contact Arunima Shukla at
410-786-5017.)\
5. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Medicare Self-Referral Disclosure Protocol; Use: Section 6409 of the
ACA requires the Secretary to establish a voluntary self-disclosure
process that allows providers of services and suppliers to self-
disclose actual or potential violations of section 1877 of the Act. In
addition, section 6409(b) of the ACA gives the Secretary authority to
reduce the amounts due and owing for the violations. To determine the
nature and extent of the noncompliance and the appropriate amount by
which an overpayment may be reduced, the Secretary must collect
relevant information regarding the arrangements and financial
relationships at issue from disclosing parties. The Secretary may also
collect supporting documentation, such as contracts, leases,
communications, invoices, or other documents bearing on the actual or
potential violation(s). Most of the information and documentation
required for submission to CMS in accordance with the SRDP is
information that health care providers of services and suppliers keep
as part of customary and usual business practices. Form Number: CMS-
10328 (OMB control number: 0938-1106); Frequency: Yearly; Affected
Public: Private Sector (business or other for-profits, not-for-profit
institutions); Number of Respondents: 470; Total Annual Responses:
356,260; Total Annual Hours: 194,250. (For policy questions regarding
this collection contact Matthew Edgar at 410-786-0698.)
6. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Medicare Participation Agreement for Physicians and Suppliers; Use:
Section 1842(h) of the Social Security Act permits physicians and
suppliers to voluntarily participate in Medicare Part B by agreeing to
take assignment on all claims for services to Medicare beneficiaries.
The law also requires that the Secretary provide specific benefits to
the physicians, suppliers and other persons who choose to participate.
The CMS-460 is the agreement by which the physician or supplier elects
to participate in Medicare. By signing the agreement to participate in
Medicare, the physician, supplier, or their authorized official agrees
to accept the Medicare-determined payment for Medicare covered services
as payment in full and to charge the Medicare Part B beneficiary no
more than the applicable deductible or coinsurance for the covered
services. For purposes of this explanation, the term ``supplier'' means
certain other persons or entities, other than physicians, that may bill
Medicare for Part B services (e.g., suppliers of diagnostic tests,
suppliers of radiology services, durable medical suppliers (DME)
suppliers, nurse practitioners, clinical social workers, physician
assistants). Institutions that render Part B services in their
outpatient department are not considered ``suppliers'' for purposes of
this agreement. Form Number: CMS-460(OMB control number: 0938-0373);
Frequency: Yearly; Affected Public: Private Sector (business or other
for-profits); Number of Respondents: 29,000; Total Annual Responses:
29,000; Total Annual Hours: 7,250. (For policy questions regarding this
collection contact Mark Baldwin at 410-786-8139.)
Dated: June 21, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2019-13608 Filed 6-25-19; 8:45 am]
BILLING CODE 4120-01-P